Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma.
Christopher A BarkerSuzanne M DufaultSarah T ArronAlan L HoAlain Patrick AlgaziLara A DunnAudrey A HumphriesCarter HultmanMing LianP Daniel KnottSue S YomPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
In patients with unresectable LA BCC, the combination of vismodegib and RT yielded high rates of LRC and PFS and durable improvements in PRQOL.